Preoperative neutrophil-to-lymphocyte ratio (NLR) may be predictive of pathologic stage in patients with bladder cancer larger than 3 cm
dc.contributor.author | Celik, O. | |
dc.contributor.author | Akand, M. | |
dc.contributor.author | Keskin, M. Z. | |
dc.contributor.author | Yoldas, M. | |
dc.contributor.author | Ilbey, Y. O. | |
dc.date.accessioned | 2020-03-26T19:25:44Z | |
dc.date.available | 2020-03-26T19:25:44Z | |
dc.date.issued | 2016 | |
dc.department | Selçuk Üniversitesi | en_US |
dc.description.abstract | OBJECTIVE: Bladder cancer (BCa) is the most common malignancy of the urinary tract. In this study, we aimed to evaluate the ability of preoperative neutrophil-to-lymphocyte ratio (NLR) to predict pathologic stage of at the time of first transurethral resection of bladder tumor (TUR-BT) in patients with BCa larger than 3 cm. PATIENTS AND METHODS: Records of consecutive patients undergoing TUR-BT for BCa with a diameter >3 cm were reviewed. A total of 222 patients were eligible for analysis, and were divided into two groups: 162 patients in non-muscle-invasive BCa (NMIBC) group and 60 patients in muscle-invasive BCa (MIBC) group. Differences in preoperative blood parameters and NLR were evaluated between groups with an unequal variance t-test. RESULTS: In the NMIBC group, 59 patients had low-grade and 103 high-grade papillary urothelial carcinomas. 60 patients had T2 stage carcinoma. The mean age of the patients was 71.8 and 75.7 years, and mean NLR was 3.44 +/- 2.03 and 4.6 +/- 2.8 in NMIBC and MIBC groups, respectively. In terms of NLR, there was a statistically significant difference between the NMIBC and MIBC groups (p = 0.005). CONCLUSIONS: Our results showed that NLR might act as a significant predictive biomarker on the staging of BCa. Also, NLR could be used as a cost-effective, simple, common usable biomarker in urology clinic practice. | en_US |
dc.identifier.endpage | 656 | en_US |
dc.identifier.issn | 1128-3602 | en_US |
dc.identifier.issue | 4 | en_US |
dc.identifier.pmid | 26957266 | en_US |
dc.identifier.scopusquality | Q2 | en_US |
dc.identifier.startpage | 652 | en_US |
dc.identifier.uri | https://hdl.handle.net/20.500.12395/33897 | |
dc.identifier.volume | 20 | en_US |
dc.identifier.wos | WOS:000373349200011 | en_US |
dc.identifier.wosquality | Q3 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | VERDUCI PUBLISHER | en_US |
dc.relation.ispartof | EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.selcuk | 20240510_oaig | en_US |
dc.subject | Bladder cancer | en_US |
dc.subject | Neutrophil | en_US |
dc.subject | Lymphocyte | en_US |
dc.subject | Muscle-invasive | en_US |
dc.subject | Stage | en_US |
dc.title | Preoperative neutrophil-to-lymphocyte ratio (NLR) may be predictive of pathologic stage in patients with bladder cancer larger than 3 cm | en_US |
dc.type | Article | en_US |